GlobeStar Therapeutics Corp (GSTC)

[SherpaDerpa]

Acquisition of Diabetes Relief still coming imo. With that, I suspect they may begin leveraging their exclusive rights to the liprostin patent with regard to diabetes treatments, and potentially initiate some form of MS testing/therapeutic treatment as well. Recent studies have shown ties between the two diseases, and I am curious if DR believes they may be able to help alleviate/revert symptoms of MS with their current methodology.

Looks to me like Diabetes Relief revenues have grown towards 6 million?

Partnership/sub-license with big pharma also in the mix?

Time will tell.

Small volume accumulator still very active - accumulating this range bit by bit and doing the best they can to keep price from running up, which is not easy given how thin this stock is now.

Liprostin Group off and running with an exclusive license to Liprostin as well after litigation settlement, but clearly more focused on the applications to COVID 19 and PAD. They still own shares here.

Looking forward to how this one plays out.

All speculative and IMO. Good luck to all holding strong here $SOAN